Lazard Asset Management’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Sell |
1,256
-38,455
| -97% | -$245K | ﹤0.01% | 2182 |
|
|
2025
Q1 | $358K | Sell |
39,711
-15,806
| -28% | -$142K | ﹤0.01% | 1499 |
|
|
2024
Q4 | $959K | Buy |
55,517
+16,076
| +41% | +$278K | ﹤0.01% | 1169 |
|
|
2024
Q3 | $630K | Buy |
39,441
+36,359
| +1,180% | +$581K | ﹤0.01% | 1290 |
|
|
2024
Q2 | $43K | Buy |
3,082
+2,907
| +1,661% | +$40.6K | ﹤0.01% | 1955 |
|
|
2024
Q1 | $2K | Sell |
175
-2,493
| -93% | -$28.5K | ﹤0.01% | 1945 |
|
|
2023
Q4 | $40K | Buy |
+2,668
| New | +$40K | ﹤0.01% | 1949 |
|
|
2023
Q3 | – | Sell |
-2,417
| Closed | -$36K | – | 2479 |
|
|
2023
Q2 | $36K | Buy |
+2,417
| New | +$36K | ﹤0.01% | 1935 |
|